<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fluorinated <z:chebi fb="3" ids="17087">ketone</z:chebi> thrombin inhibitors based on the <z:chebi fb="7" ids="16670">peptide</z:chebi> sequence <z:chebi fb="36" ids="29309">methyl</z:chebi>-(D)-Phe-Pro-Arg-CF2R were synthesized: MDL 73,446 (1, R = F); MDL 73,775 (2, R = <z:chebi fb="2" ids="50127">CF3</z:chebi>); and MDL 75,579 (3, R = CH2CH2CH3) </plain></SENT>
<SENT sid="1" pm="."><plain>These were shown to be highly effective, slow binding inhibitors of thrombin </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="3" ids="50249">Anticoagulant</z:chebi> activity was dose-dependent with 3 &gt; 2 &gt; 1 at doubling thrombin time and APTT, respectively </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="3" ids="50249">Anticoagulant</z:chebi> activity corresponded with efficacy in a platelet-dependent (<z:chebi fb="0" ids="30808">FeCl3</z:chebi>-induced) rat carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> model </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0006134'>Arterial occlusion</z:mp> was dose-dependently prolonged with 3 &gt; 2 &gt; 1 at doubling the occlusion time </plain></SENT>
</text></document>